ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 131 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,580,443 | -84.8% | 107,653 | -89.3% | 0.01% | -87.2% |
| Q4 2022 | $17,031,826 | +238.6% | 1,004,235 | +195.9% | 0.05% | +213.3% |
| Q3 2022 | $5,030,000 | +2858.8% | 339,383 | +3039.8% | 0.02% | +1400.0% |
| Q2 2022 | $170,000 | -85.1% | 10,809 | -59.4% | 0.00% | -87.5% |
| Q3 2020 | $1,142,000 | -80.2% | 26,628 | -78.4% | 0.01% | -84.0% |
| Q2 2020 | $5,766,000 | – | 123,378 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |